Clinical Trial Update: Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating exemestane (Aromasin) in combination with tamoxifen for breast cancer; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED